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Abstract 
Background: Consultations in primary care for ‘allergies’ are common and it can be difficult 
to differentiate between IgE-mediated (atopic) symptoms which respond to allergen-specific 
interventions and those which are not without performing objective tests which are largely 
unavailable in UK general practice.    
Aim: To develop and test a screening tool that can accurately discriminate between atopic and 
non-atopic individuals.  
Design and Setting: Validation study in adult volunteers aged >16 years in Scotland.  
Methods: The tool was developed using questions from a large cohort study and through 
consultation with experts. Participants answered the questions and had skin prick tests (SPT) 
to four aeroallergens (housedust mite, cat, dog, mixed grasses). Participants were classified as 
atopic if any average wheal diameter was ≥3mm greater than the negative control. Sensitivity, 
specificity, positive and negative predictive values of individual and combinations of questions 
were calculated.  
Results: 143 participants completed the questionnaire and underwent SPTs. A total of 81 (56.6 
%) were atopic. Negative predictive values for the individual questions ranged from 48.2% (55 
not atopic /114 negative answers) to 72.0% (18/25). An optimum combination of four questions 
were identified, where a negative answer to all four questions was reported by 24 participants 
and 21 (87.5%) were not atopic. 
Conclusions: We have identified a set of questions that correctly predict negative SPTs to 
common aeroallergens 88% of the time. These may be useful to exclude patients who do not 
warrant further investigation and who can reliably be advised that allergen avoidance is neither 
necessary nor helpful. 
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How this fits in: The purpose of this study was to identify simple questions which can 
accurately predict the absence of atopy without the need for expensive and time-consuming 
objective tests e.g. skin prick tests or allergen-specific IgE blood tests. These questions can 
now be developed into a screening tool to be used by health care professionals and the general 
public to exclude allergy. This will have the benefit of preventing unnecessary avoidance of 
allergens and could also be useful in excluding an allergic basis for adverse reactions to food 
which is extremely uncommon in those who are non-atopic.               
 
 
Introduction 
Allergic (IgE-mediated) disorders as a whole are responsible for substantial morbidity, 
healthcare utilisation and costs to the National Health Service (NHS).1,2 In addition, there are 
significant numbers of people who mistakenly believe they are allergic and who utilise both 
NHS and their own time and resources pursuing unnecessary investigations (e.g. conventional 
skin prick testing (SPT) and specific IgE blood testing which are both associated with a high 
level of false positives3) and pursuing alternative ‘allergy’ testing (e.g. hair analysis or 
kinesiology which have no scientific basis), as a result of which they may unnecessarily avoid 
exposure to presumed triggers.4  
However, it can often be difficult to differentiate between allergic (i.e. IgE-mediated) and non-
allergic (i.e. non-IgE-mediated) symptoms. To date, the only way of identifying non-atopic 
status (defined as negative allergy tests to one or more airborne allergens and independent of 
clinical symptoms) is to do SPT or blood tests for the presence of specific-IgE. These 
diagnostic tests are, however, expensive (blood tests) and/or often unavailable in the primary 
care setting (SPT)5; they are furthermore difficult to interpret by generalist healthcare 
professionals and also people buying blood testing kits over-the-counter because of the high 
rate of false positives. A less common manifestation of IgE-mediated disease is food allergy. 
Food allergy is commonly over-estimated, particularly among parents who often attribute 
childhood skin rashes (which are, for example, virally-induced) to food allergy.  It is 
noteworthy that IgE-mediated food allergy is uncommon in those people who are non-atopic 
(i.e. not sensitised to common airborne allergens as shown by negative skin prick/specific IgE 
tests to those allergens); in a recent study, less than 0.2% of children who were non-atopic went 
on to test positive to one of 12 food allergens.6  In adults, 10-12% of the general adult 
population think they have some type of food allergy or intolerance7, 8  whilst IgE-mediated 
food allergy can only be confirmed in 1-2%.6  This represents a five-fold over-estimation of 
food allergy which is likely to have significant cost and societal implications.1, 9  
 
Developing a screening tool to exclude allergy so that people who are non-atopic can be 
identified, either by themselves or by their nurse or doctor, could bring significant resource and 
health benefits. A simple, inexpensive, non-invasive method of screening would have the 
potential to reduce non-essential testing and referral (and therefore reduce healthcare utilisation 
and costs to the NHS) and to reassure patients as to the safety of continued exposure to allergens 
they wrongly suspect of causing their symptoms. Similar studies using a diagnostic tool to 
exclude disease in other medical fields include the use of D-Dimer test in patients with 
suspected venous thromboembolism10, 11, and the serum levels of procalcitonin as a marker for 
bloodstream infections.12 
Data from a large paediatric cohort study (further discussed below) suggests that approximately 
5-10 questions from the clinical history may accurately predict non-atopic status, but this 
requires testing in clinical practice to confirm utility.  
The aim of this study was therefore to investigate whether key clinical questions could 
accurately identify patients who are non-atopic. 
Methods 
 
Ethical approval 
Ethical approval was obtained from the South East Scotland Research Ethics Committee 02 
(SES REC 02) and Research & Development management approval was obtained from NHS 
Lothian. Amendment approval to extend the recruitment to the general public was obtained 
(SES REC 02). 
 
Participants 
Study population 
Adults aged >16 years registered with general practices, or members of the general public, in 
Lothian, Scotland were invited to participate in this study. 
 
The exclusion criteria were:  
• < 16 years old 
• pregnancy 
• uncontrolled asthma 
• a previous history of anaphylaxis  
• antihistamines in the previous 48 hours 
• unwilling or unable to give informed consent.  
 
Recruitment 
The study was advertised in general practices, in liaison with the Scottish Primary Care 
Research Network.  In the general practices, posters were displayed in the waiting area and 
flyers were handed out to people who expressed an interest. Flyers were also sent to patients 
attending designated asthma clinics. Email, posters and websites within The University of 
Edinburgh were used to inform the general public. Potential participants were asked to contact 
the researcher by phone or email and were sent the participant information sheet to read prior 
to their appointment. Participants were asked to book an appointment with the researcher for 
clinics at their GP surgery or in the Clinical Research Facility (CRF) at the Royal Infirmary 
Edinburgh (RIE). Consent forms were completed and exclusions criteria checked at the 
beginning of the appointment. Permission was taken for the results of the skin prick testing to 
be sent to the participant’s GP.  
 
Questionnaire development (Index test) 
We utilised five questions identified from the Ashford Birth Cohort Study13 as having the 
potential to accurately predict non-atopic status, but which had not been tested in clinical 
practice, as a basis for our questionnaire (see Box 1).  
Box 1: Ashford Birth Cohort Study screening questions 
 
Cullinan et al (2004)13 defined atopy as a positive SPT (≥3mm) to at least one of mixed grasses, 
cat fur and house dust mite. Parents in the Ashford Cohort answered the five allergy questions 
and parents and children were skin prick tested. The numbers of people being ‘non-atopic’ in 
relation to each negative response ranged from 63-77%; i.e. if a parent said that they had no 
history of hayfever then they had a negative allergy test to grass 77% of the time (high negative 
predictive value). We amended the wording of these questions and supplemented them with 
six additional questions identified through consultation with experienced allergy clinicians as 
1. Do you have a personal history of hay fever? 
2. Do you have a personal history of asthma?  
3. Do you have a personal history of eczema or asthma as a baby (age <2years)? 
4. Do you have a personal history of other allergy? 
5. Do any of your parents or siblings have a history of hay fever? 
also having the potential to discriminate between allergy and non-allergy. Five allergy 
clinicians were sent a short summary of the study prior to the consultation (see Appendix) and 
were asked to identify any additional questions which they felt were able to discriminate 
between atopy and non-atopy in someone presenting with suspected allergy.  All questions 
were included and the final 11 questions are shown in Box 2. 
Box 2: Questions used in screening tool 
 
 
Questionnaire completion 
Consenting participants answered the resulting 11-question screening tool relating to their 
atopic status. Data were recorded anonymously on data collection sheets. Clinical information 
and index test results were not available to the assessors of the reference standard. 
Skin prick testing (reference standard) 
Skin prick testing was performed using positive (histamine dihydrochloride) and negative 
(allergen diluents) controls, mixed grass, house dust mite (D.pteronyssinus), dog and cat 
 
1. Are you aged less than 40yrs?  
2. Do you have or have you ever had hay fever?  
3. Do any of your parents or siblings (brothers or sisters) have or have ever had hay 
fever?  
4. Do you have or have you ever had asthma?  
5. Did you ever have eczema or asthma as a baby (aged less than 2 years)?  
6. Do you have or have you ever had any other allergy?  
7. Do you ever have any symptoms of itch or sneeze 
8. Do your allergy symptoms vary when you go from place to place (e.g. on 
holiday)? 
9. Is there a specific trigger that always sets off your allergy symptoms?  
10. Do your allergy symptoms start within 30 minutes of being exposed to a specific 
trigger?  
11. Do your allergy symptoms improve after treatment with anti-histamines? 
allergens on the volar aspect of the forearm according to a standardised technique using 
individual sterile lancets. Skin wheal diameter (mm) was measured after 15 minutes using a 
measuring grid. Positive responses to allergen were defined as mean wheal sizes ≥3mm bigger 
than the negative control; negative responses were the same size or smaller than the negative 
control. Non-atopic status was defined as negative responses to all four skin prick tests; atopic 
status was defined as a positive response to ≥1 aeroallergen.  
 
Data analysis 
Using positive skin prick tests results as the gold standard for atopic status, sensitivity, 
specificity, positive and negative predictive values of the individual questions and 
combinations of questions were calculated. Confidence intervals (95%) were calculated for the 
sensitivity and specificity using standard methods for proportions. Positive and negative 
predictive values were calculated as the probability that the questionnaire responses agreed 
with the skin prick test results, where the positive predictive value was the proportion of 
patients with a positive history who were atopic and the negative predictive value was the 
proportion of patients with a negative history who were not atopic.   
Logistic regression techniques were used to identify the combination of questions which 
demonstrated the strongest association with non-atopic status.  Responses to all questions were 
considered individually; then a multivariate model was constructed by including the questions 
with the strongest associations one by one until no others questions significantly contributed to 
the fit of the final model. The contribution of each question was evaluated using likelihood 
ratio tests. Once these questions were identified it was possible to calculate the sensitivity, 
specificity, positive and negative predictive values for this combination of questions. 
Participants were defined as “questionnaire positive” if at least one response to these questions 
was positive and “questionnaire negative” if all responses were negative. All statistical analyses 
were undertaken using Stata (Stata Corporation, USA). 
Sample size 
Based on a sample size of 150, the specificity would be estimated with 95% confidence 
intervals of ± 4.8% for a specificity of 90%. The sample size was calculated using an online 
statistical tool.14 
 Results 
143 participants completed the questionnaire and underwent skin prick tests; there were no 
adverse reactions. There were no indeterminate index or reference standard results or missing 
data. The mean age of participants was 41.1 years (range 18.8-84.9), and 76.9% were female. 
A total of 81 participants (56.6%) were atopic; the rates for each allergen were 62/143 (43.4%) 
for grass, 67/143 (46.9%) house dust mite, 49/143 (34.3%) for cat and 33/143 (23.1%) for dog. 
Individual question analysis is shown in Table 1. 
We explored any correlation between questions, and whilst many of the questions were related 
to each other, none were in perfect agreement. Logistic regression techniques identified 
Questions 2, 8, 3 and 9 as being independently associated with the risk factor of being non-
atopic (Table 2).  
The negative response to Question 8 was the most associated with being not atopic (i.e. 
negative skin tests); after adjusting for the other questions, patients were four times more likely 
to have negative test results if they answered no to that question. Table 3 shows the relationship 
between the responses to these four questions and atopic status.  
This comparison of the questionnaires and skin tests gave: 
Sensitivity = 78/81 = 96.3% (95% CI 89.6, 99.2) 
Specificity = 21/62 = 33.9% (95% CI 22.3, 47.0) 
Positive predictive value = 78/119 = 65.6% (95% CI 56.3, 74.0) 
Negative predictive value = 21/24 =87.5% (95% CI 67.6, 97.3) 
This shows that the combination of Questions 2, 8, 3 and 9 had a reasonably high negative 
predictive value; most (87.5%) of those who gave negative responses to all the questions were 
not atopic (had negative skin tests).  
Discussion 
Summary 
We were able to identify four questions which were reasonably predictive of non-atopic status 
in patients with suspected allergy. This has the potential to be useful to differentiate between 
IgE-mediated and non-IgE-mediated symptoms (and so to drive treatment choices and 
avoidance advice) in primary care where diagnostic tests are not routinely available.    
Strengths and limitations 
We were able to recruit members of general practices and the general public for this work, and 
almost achieved our target sample size of 150. The screening tool is intended for use by health 
care professionals in primary care and the general population, which is where it was tested,15  
and was compared with the best gold standard available. Our definition of atopy, a positive 
skin prick test to common (country- and climate-specific) aeroallergens, has been used in other 
studies13, and our choice of skin prick testing as a gold standard is safe and feasible for 
aeroallergens.16 However, this definition of atopy gave a prevalence of 57% in our sample 
population, which is high compared with other similar studies, presumably because there was 
a higher motivation to participate amongst people who are atopic.17 This may have resulted in 
loss of power to detect important questions that predict non-atopy. 
One limitation is the sample size; in the detailed analysis, where combinations of questions 
were examined, the numbers were small, and increasing the sample population would have 
contributed more data to each combination of positive/negative to the skin prick testing and the 
questions, potentially increasing the negative predictive values and improving precision.   
Due to the nature of recruitment, advertising with posters and leaflets, we were unable to record 
how many people saw the information but declined to take part, thus preventing any 
considerations of the representativeness of the findings.  
Comparison with existing literature 
Previous work in this field has mainly focussed on developing questions which can accurately 
predict sensitisation to a suspected allergen (i.e. do positive answers to clinical questions 
predict positive skin prick or specific IgE test results).17-19 The focus of this current study, 
however, was different; we sought to identify simple questions for which ‘no’ answers could 
predict negative skin tests in a general population with a view to being able to assess atopic 
status without the need for a formal diagnostic test.  
This combination of questions compares well to other studies that have reported a negative 
predictive value for atopy including ALATOP20 in vitro multispecific IgE test which reported 
the following: 1) Sensitivity: 89.57%; 2) Specificity: 98.06%; 3) Positive predictive value: 
98.65%; 4) Negative predictive value: 85.59% . Similarly, a study looking at the accuracy of 
allergy skin prick tests in predicting allergy17, SPT was predicted to be positive in 42.6% and 
was positive in 36.1%. Depending on SPT results with the cut-off value 3 mm, prediction 
sensitivity was 77%, specificity was 65.3%, positive predictive value was 65%, and negative 
predictive value was 86%. In studies of different diagnostic tests, Wang et al11 reported a 
slightly lower sensitivity of 64% and a higher negative predictive value of 94%, concluding 
that the D-dimer assay may have a role in tailoring treatment to optimise prevention of venous 
thromboembolism. Similar results were found for the predictive value of procalcitonin in 
excluding bloodstream infections and managing antibiotic usage (83% sensitivity and 94% for 
negative predictive value).12 
When a test has a high sensitivity, a negative test rules out the diagnosis21, and our study reports 
a high sensitivity (96%) and negative predictive value (88%). We therefore think we can be 
fairly confident that this result using the 4 questions has a high negative predictive value (as it 
is almost 90%), although the numbers were relatively small. 
 
Implications for practice 
We were able to identify four questions which were predictive of non-atopic status. Our results 
provide useful data for the development of a screening tool for non-atopic status in people with 
suspected allergy, although the questions need further validation in a larger, independent 
population of consecutively enrolled patients. This would increase the numbers in the 
combination analysis and increase precision. The screening tool could then be confidently used 
by healthcare professionals or patients to accurately predict non-atopic status. 
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Table 1: Validity of each question as a tool for identifying atopic status 
Question Number (%) 
with 
negative 
response to 
question 
Sensitivity % 
(95% ci) 
Specificity % 
(95% ci) 
Positive 
Predictive 
Value % 
(95% ci) 
Negative 
Predictive 
Value % 
(95% ci) 
1. Are you aged 
less than 40yrs? 
73 (51.1%) 53 (42-64) 56 (43-69) 61 (49-73) 48 (36-60) 
2. Do you have or 
have you ever had 
hayfever? 
73 (51.0%) 68 (57-78) 75 (63-86) 79 (67-87) 64 (52-75) 
3. Do any of your 
parents or siblings 
(brothers or sisters) 
have or have ever 
had hayfever? 
79 (55.2%) 59 (48-70) 74 (62-84) 75 63-85) 58 (47-69) 
4. Do you have or 
have you ever had 
asthma? 
96 (67.1%) 43 (32-54) 80 (69-90) 74 (60-86) 52 (42-62) 
5. Did you ever 
have eczema or 
asthma as a baby 
(aged less than 2 
years)? 
114 (79.7%) 27 (18-38) 89 (78-95) 76 (56-90) 48 (38-58 
6. Do you have or 
have you ever had 
any other allergy? 
56 (39.2%) 69 (58-79) 50 (37-62) 64 (53-74) 55 (41-69) 
7. Do you ever 
have any 
symptoms of itch 
or sneeze? 
25 (17.5%) 91 (83-96) 29 (18-42) 62 (53-71) 72 (51-88) 
8. Do your allergy 
symptoms vary 
when you go from 
place to place (e.g. 
on holiday)? 
61 (43.0%) 75 (64-84) 66 (53-780 74 (63-83) 67 (54-79) 
9. Is there a 
specific trigger that 
always sets off 
your allergy 
symptoms? 
76 (53.2%) 62 (50-72) 73 (60-83) 74 (63-84) 59 (47-70) 
10. Do your 
allergy symptoms 
start within 30 
minutes of being 
exposed to a 
specific trigger? 
64 (44.8%) 69 (58-79) 63 (50-75) 71 (60-81) 61 (48-73) 
11. Do your 
allergy symptoms 
improve after 
treatment with 
anti-histamines? 
58 (40.6%) 72 (61-81) 56 (43-69) 68 (57-78) 60 (47-73) 
 
  
Table 2: Results from logistic regression (outcome is not atopy: i.e. negative skin tests) 
Negative response to: Adjusted* Odds Ratio (95% ci) p-value 
2. Do you have or have you 
ever had hayfever? 
2.44 (0.99, 6.00) 0.05 
8. Do your allergy symptoms 
vary when you go from place 
to place (e.g. on holiday)? 
4.00 (1.67, 9.57) 0.002 
3. Do any of your parents or 
siblings (brothers or sisters) 
have or have ever had 
hayfever? 
3.19 (1.37, 7.44) 0.01 
9. Is there a specific trigger 
that always sets off your 
allergy symptoms? 
3.09 (1.32, 7.22) 0.01 
*all odds ratios are adjusted for responses to the other three questions  
 
  
Table 3: Responses to the four key questions and atopic status 
 
 Skin prick test  
 Atopic  Not atopic  Total 
Test (questions)    
Questionnaire positive 78 41 119 
Questionnaire negative 3 21 24 
Total 81 62 143 
 
Questionnaire positive = At least one positive response 
Questionnaire negative = all responses negative  
Appendix:  Study summary for allergy specialists 
Developing and testing a screening tool to accurately predict non-atopic status in patients with suspected 
allergy 
Background 
Disorders such as asthma, rhinitis and urticaria are extremely common in Scotland, potentially affecting up to one 
in three of the population1. The commonest manifestations are respiratory and dermatological, and are often 
caused by exposure to allergens such as pollens and house dust mites mediated through the production of allergen-
specific IgE antibodies and subsequent histamine release.  Allergic (IgE-mediated) disorders as a whole are 
responsible for substantial morbidity, healthcare utilisation (over 4% of GP consultations and 1.5% of hospital 
admissions in Scotland are for allergic diseases) and costs to the NHS1. In addition, there are significant numbers 
of people who mistakenly believe they are allergic and who utilise both NHS and their own time and resources 
pursuing unnecessary investigations (e.g. conventional skin prick testing (SPT) and specific IgE blood testing 
which are both associated with a high level of false positives) and pursuing alternative ‘allergy’ testing (e.g. hair 
analysis or kinesiology which have no scientific basis), as a result of which they may unnecessarily avoid exposure 
to presumed triggers4. For example, 10-12% of the general adult population think they have some type of food 
allergy or intolerance7, 8  whilst IgE-mediated food allergy can only be identified in 1-2%6.  This represents a 
five-fold over-estimation of food allergy which is likely to have significant cost and societal implications1, 9. 
However, it can often be difficult to differentiate between allergic (i.e. IgE-mediated) and non-allergic (i.e. non 
IgE-mediated) symptoms. To date, the only way of identifying non-atopic status (defined as negative allergy tests 
to one or more airborne allergens and independent of clinical symptoms) is to do SPT or blood tests for the 
presence of specific-IgE. These diagnostic tests are, however, expensive and often unavailable in the primary care 
setting, and are furthermore difficult to interpret by healthcare professionals and also people buying blood testing 
kits over-the-counter. Negative allergy tests alone are a relatively accurate predictor of non-allergy22, although it 
is not clear at present whether a negative allergy history accurately predicts negative allergy tests.   
Outline of this project 
This study will investigate whether key clinical questions can accurately identify patients who are non-atopic. We 
propose to develop an instrument that is comprised of validated questions, which can identify those patients for 
whom an allergy test is so likely to be negative that it is not worth doing (i.e. a very high negative predictive 
value). This has the potential to be useful both for clinicians and patients in streamlining care in a cost-effective 
manner. 
Collaboration with colleagues from Imperial College London has enabled us to analyse unpublished data from the 
Ashford Birth Cohort, providing useful information about parental and child allergy status.  Parents answered the 
following five allergy questions and parents and children were skin prick tested: 
1. Do you have a personal history of hayfever? 
2. Do you have a personal history of asthma?  
3. Do you have a personal history of eczema or asthma as a baby (age <2years)? 
4. Do you have a personal history of other allergy? 
5. Do any of your parents or siblings have a history of hayfever? 
Atopy was defined as a positive SPT (≥3mm) to at least one of mixed grasses, cat fur and house dust mite. The 
numbers of people being ‘non-atopic’ in relation to each negative response ranged from 63-77%; i.e. if a parent 
said that they had no history of hayfever then they had a negative allergy test to grass 77% of the time (high 
negative predictive value). A negative response to all the questions was associated with a high rate of negative 
allergy tests in adults (83%). Results from the same study in children were similar (89%), however numbers were 
smaller. High specificity (ideally 95%) is required for the tool to be useful in clinical practice.  
These five questions will be used as the basis for the screening questionnaire. Additionally, we will identify any 
other questions that, according to experienced allergy clinicians, discriminate between allergy and non-allergy 
and test them with the questions identified above to create the combination with the highest negative predictive 
value.  
 
 
We now wish to find out which questions, addition to those listed above, discriminate between atopy and non-
atopy in someone presenting with suspected allergy.   
   
Name:  _________________________________________________________ 
 
Position: _________________________________________________________ 
 
Questions: 
 
1.  __________________________________________________________________ 
2.  __________________________________________________________________ 
3.  __________________________________________________________________   
 
 
 
 
